Division of Hematology News and Updates

1 - 10 of 34

Breakthrough New Therapies Approved for the Treatment of Sickle Cell Disease

The US Food and Drug Administration has approved two new breakthrough therapies for patients with sickle cell disease (SCD), and we believe both may enhance the treatment of our patients here at CHOP.

Read more

New Studies Provide Important New Clues For Treating Red Blood Cell Disorders

Published on in CHOP News

Stefano Rivella, PhD, an expert in creating the next-generation lentiviral vectors for the cure of hemoglobinopathies including sickle cell disease (SCD), as well as a leader in the discovery of erythroid and iron disorders including beta-thalassemia, has led three new published studies that make significant contributions to the scientific body of literature regarding red blood cells, and how manipulating the production of red cells can lead to the development of new disease-modifying therapies.

Joe Oved, MD, Joins the Comprehensive Bone Marrow Failure Center at CHOP

Published on in CHOP News

Joe Oved, MD

Dr. Oved brings deep expertise to the group, having completed scientific and clinical training that included tenures as a Fulbright Fellow with the Weizmann Institute in Israel, the NYU School of Medicine with two years as a Howard Hughes Medical Fellow, followed by a residency in Pediatrics at NYP Weill Cornell Medical College.


Pages